| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.2 |
0.0003 |
| mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0005 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.17 |
0.0006 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |